Blood Plasma Derivatives Market Size, Trend Analytics and Forecast to 2025
Market Analysis:
Various factors are propelling the blood
plasma derivatives market growth. These factors, as per the new MRFR report,
include growing demand for plasma derivative-based therapies, increasing
incidence of hemophilia, increasing funding for R&D activities,
advancements in technology, and growing approval from regulatory bodies.
Additional factors propelling market growth include increasing prevalence of
life-threatening diseases, including hepatitis and HIV, and various
non-government and government organizations conducting and promoting blood
donation camps.
The global Blood
Plasma Derivatives Market is
predicted to touch USD 33,590 million at a 10.1% CAGR over
the forecast period (2019-2025), states the new Market Research Future
(MRFR) report. Plasma is a fluid portion of the blood which contains protein
and blood cells that are responsible for blood clotting. The plasma derivative
is obtained from definite plasma proteins through fractionation. Then the
derivatives are heat-treated or solvent detergent-treated for killing viruses.
Blood plasma helps in maintaining the blood pressure and assist in exchanging
of essential minerals such as potassium and sodium for maintaining the body’s
pH balance.
The rise in global geriatric population also
fuels the growth of the blood plasma derivatives market. The elderly population
is generally at more risk of acquiring life-threatening diseases which
consequently necessitates treatment and further intensifies the growth of the
market.
Other driving factors include raising
awareness regarding blood and plasma donation and advancement in the
preservation techniques of blood plasma. Also, an outlay of substantial amounts
on research & development activities and expanding range of clinical
applications of blood plasma derivatives are expected to be a tailwind for the
growth of the global blood plasma derivatives market.
Key Players:
·
Bain Capital
·
Biotest AG
·
Octapharma AG
·
CSL Limited
·
Baxter International Inc
·
Fusion Healthcare
·
SK Plasma
·
Grifols
Market Segmentation:
·
The MRFR report provides an all-inclusive
segmental analysis of the blood plasma derivatives market report on the basis
of type, end user, and application.
·
Based on type, the blood plasma derivatives
market is segmented into fresh frozen plasma (FFP), intravenous immunoglobulin
(IVIG), anti-thrombin, albumin, and others.
·
Based on application, the blood plasma
derivatives market is segmented into Thrombocytosis, Hepatitis C, Hepatitis B,
HIV, Hemophilia B, Hemophilia A, and others. Others include Von Willebrand
disease.
·
Based on end users, the blood plasma
derivatives market is segmented into blood transfusion centers, diagnostic
centers, hospitals, and others.
Regional Analysis:
By region, the blood plasma derivatives market
report covers the latest trends and growth opportunities across the Asia
Pacific, Europe, North America, and the Middle East and Africa. Of these, North
America will spearhead the blood plasma derivatives market over the forecast
period. It is predicted to grow at a 4.25% CAGR. This region is the largest
market for needle and syringe. Awareness about the usage of plasma derivatives
for patients with infectious diseases is boosting the market growth in the
region.
The blood plasma derivatives market in Europe
is predicted to have the second-largest share in the market over the forecast
period. It is predicted to grow at a 3.8% CAGR. Factors aiding growth in the
region include extensive research on safe blood transfusion in research
laboratories and healthcare organizations.
The blood plasma derivatives market in the
APAC region is predicted to grow at the fastest pace over the forecast period.
This is chiefly due to the burgeoning demand for plasma derivatives for
inactivation of HIV. India is the key contributor in this region.
The blood plasma derivatives market in the
Middle East and Africa is predicted to have a steady growth over the forecast
period.
Comments
Post a Comment